Here, the impact of triptolide on melanoma was investigated in both cells and mouse models, as well as its impact on the Src-ERK pathway, finding that triptolide inhibits melanoma cell growth through suppression of the Src-ERK axis. This evidence concerns the gene SRC and melanoma.